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urham, North Carolina
or those who perform coronary revascularization every day,
he decision for angioplasty seems as natural and well
onsidered as a decision to don an umbrella in the rain.
rom the perspective of patients and their families initially
aced with the prospect of coronary artery disease and the
eed for coronary interventions, this decision is much less
ertain and often invokes questions, fears, and doubts.
opping the list of questions are: “Do I really need this?” “Is
his the best hospital and medical team to perform this
rocedure?”
See page 136
As a reflection of the exceptional group of colleagues who
ompose cardiology, extensive tools and systems have been
eveloped to help inform these concerns. Regarding the
uestion of whether to perform coronary revascularization,
ecades of randomized trials and pages of expert guidelines
rovide clear direction regarding the benefits, risks, and
ndications for intervention. To address the question “Is this
he best facility?,” cardiology has been far out in front of the
edical field in establishing national registries by which to
dentify best care.
In this issue of JACC: Cardiovascular Interventions, Klein
t al. (1) consider the ability of the ACC-NCDR (American
ollege of Cardiology–National Cardiovascular Data Reg-
stry) database to identify quality care according to risk-
djusted mortality rates. Following a hypothesis put forth by
uft and Romano (2) that hospital outlier status should be
elated to future performance, this study examines changes
n institutional rankings over 4 years according to risk-
Editorials published in JACC: Cardiovascular Interventions reflect the views of the
uthors and do not necessarily represent the views of JACC: Cardiovascular Interven-
ions or the American College of Cardiology.
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arolina. Dr. Jollis has received grant support from United Healthcare, Genentech,
nd Sanofi Aventis.djusted mortality. From a practical standpoint, if better or
orse quality can be identified according to risk-adjusted
ortality, one would expect to find temporal relationships.
or those hospitals that did not implement significant
rogrammatic changes, “high” or “low” status should be
onsistently identified in contiguous years.
The longitudinal findings of the study are slightly chal-
enging to interpret from the perspective of temporal trends,
s only 180 of 403 hospitals included in the analyses
articipated all 4 years. Annual enrollment in NCDR
ncreased from 228 to 339 hospitals between 2001 and
004. For programs participating in NCDR 2 or more
ears, rankings varied considerably by year. Not surprisingly,
he programs with the fewest number of annual cases
xhibited the greatest variation, an average of 53 places
etween years.
Considering quality according to the highest risk-
djusted mortality rates, 64 hospitals ranked among the top
0 institutions in any given year, 8 in 2 years, and 3 in 3 or
ore years. Thus, most hospitals were unlikely to be
dentified as high outliers on a consistent basis according to
isk-adjusted mortality.
What is the significance of these findings? First, this
tudy confirms the work of Luft and Romano (2) that
mong low risk patients, outlier status is not predictive of
ubsequent hospital performance. With coronary angio-
lasty mortality rates approaching 1%, there are simply too
ew adverse outcomes to reliably identify hospitals that
ttain better or worse outcomes according to consistent
early trends. Second, this work provides empiric evidence
egarding the challenge of identifying “quality low volume
ospitals.” Rankings that vary by an average of 53 places
etween years suggest that chance plays a substantial role in
odel estimates when dealing with small samples and
nfrequent outcomes.
In considering model performance, the work refers to
-indices of 0.9, suggesting “quite high” discrimination and
good confidence in the estimated expected probabilities for
alculation of the O/E ratio” (1). With such high C-indices,
ow is it possible to find such variation in rankings? The
-index is a single measure of model performance and its
ignificance should not be overestimated. This index simply
epresents the proportion of all possible pairs of patients
ith different outcomes (1 survivor and 1 death) for whom
he regression model assigns higher risk to patients who
ied. The index does not take into account the magnitude of
his difference. For most pairs, the models will estimate that
oth will survive, yet the C-index considers the assignment
f a slightly higher risk as “discriminating.” A high C-index
hould not be confused with the ability to predict which
atients will die. To directly consider the “estimated ex-
ected probabilities,” one must examine model calibration
ather than the C-index, or the extent to which predicted
m
s
c
c
i
a
a
c
b
r
i
a
b
a
n
m
c
t
S
f
q
T
t
t
r
R
3
2
R
1
2
K
p
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 2 , N O . 2 , 2 0 0 9
F E B R U A R Y 2 0 0 9 : 1 4 4 – 5
Jollis
Editorial Comment
145ortality corresponds to observed mortality across the
pectrum of risk.
The C-index and model calibration are 2 of many
onsiderations of our ability to risk adjust and identify best
are. Risk adjustment efforts should also be gauged accord-
ng to the consistency of risk factor and outcomes reporting
cross hospitals, event rates, sample size, patient selection,
nd longitudinal correlations of hospital rank such as that
onducted by Klein et al. (1). With rankings that can change
y 50 places in a given year, systematic assurance of uniform
isk factor and complication reporting is of particular
mportance.
With continued refinement of our techniques including
nalyses such as these, cardiology has substantial resources
y which to uphold the quality of coronary revascularization
nd definitively address patient concerns. However, coro-
ary angioplasty deaths are so infrequent that risk-adjusted
odels alone will remain limited in their ability to fully
haracterize quality care. Extending the weather analogy,
here are simply too few storms in cities such as Palm
prings to statistically judge rain forecasting skills, and too
ew deaths in coronary interventions to reliably identify cuality programs, particularly among low volume hospitals.
hus, coronary interventional quality efforts must continue
o wield a broad umbrella of multiple metrics including
raining and practice standards, process measurements, and
isk-adjusted outcomes.
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